BIOMARKER IDENTIFICATION IN BREAST CANCER: BETA-ADRENERGIC RECEPTOR SIGNALING AND PATHWAYS TO THERAPEUTIC RESPONSE
Recent preclinical studies have associated beta-adrenergic receptor (β-AR) signaling with breast cancer pathways such as progression and metastasis. These findings have been supported by clinical and epidemiological studies which examined the effect of beta-blocker therapy on breast cancer metastasi...
Main Authors: | , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2013-03-01
|
Series: | Computational and Structural Biotechnology Journal |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2001037014601124 |
id |
doaj-a7e010a8f7214654a43fd699ebe14105 |
---|---|
record_format |
Article |
spelling |
doaj-a7e010a8f7214654a43fd699ebe141052020-11-24T22:43:57ZengElsevierComputational and Structural Biotechnology Journal2001-03702013-03-016710.5936/csbj.201303003BIOMARKER IDENTIFICATION IN BREAST CANCER: BETA-ADRENERGIC RECEPTOR SIGNALING AND PATHWAYS TO THERAPEUTIC RESPONSELiana E. Kafetzopoulou0David J. Boocock1Gopal Krishna R. Dhondalay2Desmond G. Powe3Graham R. Ball4John van Geest Cancer Research Centre, School of Science and Technology, Nottingham Trent University, Nottingham, NG11 8NS, UKJohn van Geest Cancer Research Centre, School of Science and Technology, Nottingham Trent University, Nottingham, NG11 8NS, UKJohn van Geest Cancer Research Centre, School of Science and Technology, Nottingham Trent University, Nottingham, NG11 8NS, UKJohn van Geest Cancer Research Centre, School of Science and Technology, Nottingham Trent University, Nottingham, NG11 8NS, UKJohn van Geest Cancer Research Centre, School of Science and Technology, Nottingham Trent University, Nottingham, NG11 8NS, UKRecent preclinical studies have associated beta-adrenergic receptor (β-AR) signaling with breast cancer pathways such as progression and metastasis. These findings have been supported by clinical and epidemiological studies which examined the effect of beta-blocker therapy on breast cancer metastasis, recurrence and mortality. Results from these studies have provided initial evidence for the inhibition of cell migration in breast cancer by beta-blockers and have introduced the beta-adrenergic receptor pathways as a target for therapy. This paper analyzes gene expression profiles in breast cancer patients, utilising Artificial Neural Networks (ANNs) to identify molecular signatures corresponding to possible disease management pathways and biomarker treatment strategies associated with beta-2-adrenergic receptor (ADRB2) cell signaling. The adrenergic receptor relationship to cancer is investigated in order to validate the results of recent studies that suggest the use of beta-blockers for breast cancer therapy. A panel of genes is identified which has previously been reported to play an important role in cancer and also to be involved in the beta-adrenergic receptor signaling.http://www.sciencedirect.com/science/article/pii/S2001037014601124Artificial Neural NetworksMicroarray DataBeta-2-Adrenergic Receptorbeta-blockers |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Liana E. Kafetzopoulou David J. Boocock Gopal Krishna R. Dhondalay Desmond G. Powe Graham R. Ball |
spellingShingle |
Liana E. Kafetzopoulou David J. Boocock Gopal Krishna R. Dhondalay Desmond G. Powe Graham R. Ball BIOMARKER IDENTIFICATION IN BREAST CANCER: BETA-ADRENERGIC RECEPTOR SIGNALING AND PATHWAYS TO THERAPEUTIC RESPONSE Computational and Structural Biotechnology Journal Artificial Neural Networks Microarray Data Beta-2-Adrenergic Receptor beta-blockers |
author_facet |
Liana E. Kafetzopoulou David J. Boocock Gopal Krishna R. Dhondalay Desmond G. Powe Graham R. Ball |
author_sort |
Liana E. Kafetzopoulou |
title |
BIOMARKER IDENTIFICATION IN BREAST CANCER: BETA-ADRENERGIC RECEPTOR SIGNALING AND PATHWAYS TO THERAPEUTIC RESPONSE |
title_short |
BIOMARKER IDENTIFICATION IN BREAST CANCER: BETA-ADRENERGIC RECEPTOR SIGNALING AND PATHWAYS TO THERAPEUTIC RESPONSE |
title_full |
BIOMARKER IDENTIFICATION IN BREAST CANCER: BETA-ADRENERGIC RECEPTOR SIGNALING AND PATHWAYS TO THERAPEUTIC RESPONSE |
title_fullStr |
BIOMARKER IDENTIFICATION IN BREAST CANCER: BETA-ADRENERGIC RECEPTOR SIGNALING AND PATHWAYS TO THERAPEUTIC RESPONSE |
title_full_unstemmed |
BIOMARKER IDENTIFICATION IN BREAST CANCER: BETA-ADRENERGIC RECEPTOR SIGNALING AND PATHWAYS TO THERAPEUTIC RESPONSE |
title_sort |
biomarker identification in breast cancer: beta-adrenergic receptor signaling and pathways to therapeutic response |
publisher |
Elsevier |
series |
Computational and Structural Biotechnology Journal |
issn |
2001-0370 |
publishDate |
2013-03-01 |
description |
Recent preclinical studies have associated beta-adrenergic receptor (β-AR) signaling with breast cancer pathways such as progression and metastasis. These findings have been supported by clinical and epidemiological studies which examined the effect of beta-blocker therapy on breast cancer metastasis, recurrence and mortality. Results from these studies have provided initial evidence for the inhibition of cell migration in breast cancer by beta-blockers and have introduced the beta-adrenergic receptor pathways as a target for therapy. This paper analyzes gene expression profiles in breast cancer patients, utilising Artificial Neural Networks (ANNs) to identify molecular signatures corresponding to possible disease management pathways and biomarker treatment strategies associated with beta-2-adrenergic receptor (ADRB2) cell signaling. The adrenergic receptor relationship to cancer is investigated in order to validate the results of recent studies that suggest the use of beta-blockers for breast cancer therapy. A panel of genes is identified which has previously been reported to play an important role in cancer and also to be involved in the beta-adrenergic receptor signaling. |
topic |
Artificial Neural Networks Microarray Data Beta-2-Adrenergic Receptor beta-blockers |
url |
http://www.sciencedirect.com/science/article/pii/S2001037014601124 |
work_keys_str_mv |
AT lianaekafetzopoulou biomarkeridentificationinbreastcancerbetaadrenergicreceptorsignalingandpathwaystotherapeuticresponse AT davidjboocock biomarkeridentificationinbreastcancerbetaadrenergicreceptorsignalingandpathwaystotherapeuticresponse AT gopalkrishnardhondalay biomarkeridentificationinbreastcancerbetaadrenergicreceptorsignalingandpathwaystotherapeuticresponse AT desmondgpowe biomarkeridentificationinbreastcancerbetaadrenergicreceptorsignalingandpathwaystotherapeuticresponse AT grahamrball biomarkeridentificationinbreastcancerbetaadrenergicreceptorsignalingandpathwaystotherapeuticresponse |
_version_ |
1725693691987755008 |